| Analysis | Metabolite Name | Measured Value | Units | Treament | Exposure |
|---|---|---|---|---|---|
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 35926024 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 41881580 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 43005552 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 44196036 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 45594252 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 46310028 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 47954888 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 48169884 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 48504844 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 50010604 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 50532016 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 50620100 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 52273824 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 52944888 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 57977408 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 58583992 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 58813888 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 59828492 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 63702192 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 69836232 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 70501392 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 74322552 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 76713944 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 79885048 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 81897488 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 84455744 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 87412056 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 92740400 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 94553160 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 95943944 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 101247544 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPE (16:0) | 112370592 | Area under curve | Water | Air |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|